| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-07 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |